A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy

  • Anselm K Gitt, Peter Bramlage, Steffen Schneider, Diethelm Tschöpe
  • Cardiovascular Diabetology, January 2015, Springer Science + Business Media
  • DOI: 10.1186/s12933-015-0172-9

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Peter Bramlage